• 2022
  Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, Rouilly V, Saint-André V, Dott T, Pozo AR, Yatim N, Schwartz O, Cervantes-Gonzalez M, Ghosn J, Bastard P, Casanova JL, Szwebel TA, Terrier B, Conlon N, O'Farrelly C, Cheallaigh CN, Bourke NM, Duffy D, Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity., Nat Commun 2022 Nov; 13(1): 7254.
• 2021
  Frumholtz L, Bouaziz JD, Battistella M, Hadjadj J, Chocron R, Bengoufa D, Le Buanec H, Barnabei L, Meynier S, Schwartz O, Grzelak L, Smith N, Charbit B, Duffy D, Yatim N, Calugareanu A, Philippe A, Guerin CL, Joly B, Siguret V, Jaume L, Bachelez H, Bagot M, Rieux-Laucat F, Maylin S, Legoff J, Delaugerre C, Gendron N, Smadja DM, Cassius C, , , Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak., Br J Dermatol 2021 12; 185(6): 1176-1185.
• 2021
  Boussier J, Yatim N, Marchal A, Hadjadj J, Charbit B, El Sissy C, Carlier N, Pène F, Mouthon L, Tharaux PL, Bergeron A, Smadja DM, Rieux-Laucat F, Duffy D, Kernéis S, Frémeaux-Bacchi V, Terrier B, , Severe COVID-19 is associated with hyperactivation of the alternative complement pathway., J Allergy Clin Immunol 2021 Nov; (): .
• 2021
  Smith N, Goncalves P, Charbit B, Grzelak L, Beretta M, Planchais C, Bruel T, Rouilly V, Bondet V, Hadjadj J, Yatim N, Pere H, Merkling SH, Ghozlane A, Kernéis S, Rieux-Laucat F, Terrier B, Schwartz O, Mouquet H, Duffy D, Di Santo JP, , Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection., Nat Immunol 2021 Sep; 22(11):1428-1439.
• 2021
  Yatim N, Boussier J, Tetu P, Smith N, Bruel T, Charbit B, Barnabei L, Corneau A, Da Meda L, Allayous C, Baroudjian B, Jebali M, Herms F, Grzelak L, Staropoli I, Calmettes V, Hadjadj J, Peyrony O, Cassius C, LeGoff J, Kramkimel N, Aractingi S, Fontes M, Blanc C, Rieux-Laucat F, Schwartz O, Terrier B, Duffy D, Lebbé C, , Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection., Sci Adv 2021 08; 7(34): .
• 2021
  Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B, , Platelet activation in critically ill COVID-19 patients., Ann Intensive Care 2021 Jul; 11(1): 113.
• 2021
  Courties A, Boussier J, Hadjadj J, Yatim N, Barnabei L, Péré H, Veyer D, Kernéis S, Carlier N, Pène F, Rieux-Laucat F, Charbit B, Bondet V, Duffy D, Berenbaum F, Terrier B, Sellam J, , Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients., Sci Rep 2021 06; 11(1): 11886.
• 2020
  Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B, , Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients., Science 2020 08; 369(6504): 718-724.
• 2020
  Smadja DM, Guerin CL, Chocron R, Yatim N, Boussier J, Gendron N, Khider L, Hadjadj J, Goudot G, Debuc B, Juvin P, Hauw-Berlemont C, Augy JL, Peron N, Messas E, Planquette B, Sanchez O, Charbit B, Gaussem P, Duffy D, Terrier B, Mirault T, Diehl JL, , Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients., Angiogenesis 2020 Nov;23(4):611-620.
• 2018
  Perot BP, Boussier J, Yatim N, Rossman JS, Ingersoll MA, Albert ML, Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes, Cell Death Dis 2018 05;9(5):539.
• 2017
  Yatim N, Cullen S, Albert ML, Dying cells actively regulate adaptive immune responses, Nat. Rev. Immunol. 2017 Mar;.
• 2015
  Yatim N, Jusforgues-Saklani H, Orozco S, Schulz O, Barreira da Silva R, Reis E Sousa C, Green DR, Oberst A, Albert ML, RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells, Science. 2015 Sep 24. pii: aad0395. [Epub ahead of print].
• 2015
  Barreira da Silva R, Laird ME, Yatim N, Fiette L, Ingersoll MA, Albert ML, Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy, Nat. Immunol. 2015 Aug;16(8):850-8.
• 2014
  Orozco S, Yatim N, Werner MR, Tran H, Gunja SY, Tait SW, Albert ML, Green DR, Oberst A, RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis, Cell Death Differ. 2014 Oct;21(10):1511-21.
• 2013
  Tait SW, Oberst A, Quarato G, Milasta S, Haller M, Wang R, Karvela M, Ichim G, Yatim N, Albert ML, Kidd G, Wakefield R, Frase S, Krautwald S, Linkermann A, Green DR, Widespread mitochondrial depletion via mitophagy does not compromise necroptosis, Cell Rep 2013 Nov;5(4):878-85.
• 2011
  Yatim N, Albert ML, Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity, Immunity 2011 Oct;35(4):478-90.